IMPACT OF FIX ACTIVITY ASSAY RESULTS DETERMINED WITH ONE-STAGE CLOTTING AND CHROMOGENIC ASSAYS ON THE CLASSIFICATION OF HAEMOPHILIA B

被引：0
|
作者：
Pavic, J. [1 ,2 ]
Milos, M. [3 ]
Herak, Coen D. [3 ]
Juros, Fressl G. [4 ]
Boban, A. [5 ]
Bilic, E. [6 ]
Salek, Zupancic S. [7 ]
Zadro, R. [8 ]
机构：
[1] Gen Cty Hosp Livno, Dept Med Biochem, Livno, Bosnia & Herceg
[2] Gen Cty Hosp Livno, Haematol Lab, Livno, Bosnia & Herceg
[3] Univ Hosp Ctr Zagreb, Dept Lab Diagnost, Zagreb, Croatia
[4] Srebrnjak Childrens Hosp, Dept Clin Lab Diagnost, Zagreb, Croatia
[5] Univ Hosp Ctr Zagreb, Dept Internal Med, Zagreb, Croatia
[6] Univ Hosp Ctr Zagreb, Dept Pediat, Zagreb, Croatia
[7] Univ Zagreb, Sch Med, Zagreb, Croatia
[8] St Catherine Specialty Hosp, Med Biochem Lab, Zagreb, Croatia
来源：
HAEMOPHILIA | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO-09
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [21] Comparison of the behavior of different factor VIII products measured with the chromogenic Factor VIII activity assay and the FVIII one-stage clotting assay
    Duren, Clintvan
    Polenewen, Robert
    Brons, Paul
    Laros, Britta
    Schutgens, Roger
    Van Heerde, Waander L.
    HAEMOPHILIA, 2014, 20 : 37 - 37
  • [22] Prevalence of discrepancy between one-stage and chromogenic FVIII activity assays and the mutation profile in Polish mild/moderate haemophilia A patients
    Baran, Beata
    Odnoczko, Edyta
    Stefanska-Windyga, Ewa
    Pavlova, Anna
    Oldenburg, Johannes
    Windyga, Jerzy
    HAEMOPHILIA, 2016, 22 : 75 - 75
  • [23] Pharmacokinetics of recombinant factor VIII (recombinate) using one-stage clotting and chromogenic factor VIII assay
    Lee, CA
    Owens, D
    Bray, G
    Giangrande, P
    Collins, P
    Hay, C
    Gomperts, E
    Schroth, P
    Barrowcliffe, T
    THROMBOSIS AND HAEMOSTASIS, 1999, 82 (06) : 1644 - 1647
  • [24] One-stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype
    Cid, A. R.
    Calabuig, M.
    Cortina, V.
    Casana, P.
    Haya, S.
    Moret, A.
    Cabrera, N.
    Aznar, J. A.
    HAEMOPHILIA, 2008, 14 (05) : 1049 - 1054
  • [25] Novel mutations associated with a discrepancy between one-stage and chromogenic FVIII activity assays
    Provaznikova, D.
    Houskova, K.
    Radovska, A.
    Salaj, P.
    Hrachovinova, I.
    HAEMOPHILIA, 2015, 21 (04) : E330 - E332
  • [26] One-stage clotting versus chromogenic assays for assessing recombinant factor VIII: two faces of a haemostasis coin
    Lippi, Giuseppe
    Franchini, Massimo
    Favaloro, Emmanuel. J.
    BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (01) : 1 - 3
  • [27] The activity of glycoPEGylated recombinant FVIII (N8-GP) can be measured in both two-stage chromogenic and one-stage clotting assays
    Krogh-Meibom, T.
    Olsen, E. H. N.
    Kjalke, M.
    Ezban, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1042 - 1042
  • [28] The biological activity of GlycoPEGylated recombinant FIX (N9-GP) is similar in two-stage chromogenic assays, in Synthafax®-based one-stage clot assay and in TEG assay using blood from hemophilia B patients
    Holm, Pernille Kaae
    Sorensen, Mette Hogh
    Hermit, Mette Brunsgaard
    Ezban, Mirella
    HAEMOPHILIA, 2014, 20 : 24 - 24
  • [29] Haemophilia A mutations in patients with non-severe phenotype associated with a discrepancy between one-stage and chromogenic factor VIII activity assays
    Pavlova, Anna
    Delev, Daniel
    Pezeshkpoor, Behnaz
    Mueller, Jens
    Oldenburg, Johannes
    THROMBOSIS AND HAEMOSTASIS, 2014, 111 (05) : 851 - 861
  • [30] FACTOR-VIII ACTIVITY AS MEASURED BY AN AMIDOLYTIC ASSAY COMPARED WITH A ONE-STAGE CLOTTING ASSAY
    TRIPODI, A
    MANNUCCI, PM
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1986, 86 (03) : 341 - 344
12345